These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. McCarthy K; Maguire T; McGreal G; McDermott E; O'Higgins N; Duffy MJ Int J Cancer; 1999 Feb; 84(1):44-8. PubMed ID: 9988231 [TBL] [Abstract][Full Text] [Related]
3. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Sier CF; Kubben FJ; Ganesh S; Heerding MM; Griffioen G; Hanemaaijer R; van Krieken JH; Lamers CB; Verspaget HW Br J Cancer; 1996 Aug; 74(3):413-7. PubMed ID: 8695357 [TBL] [Abstract][Full Text] [Related]
4. Detection of matrix metalloproteinase activity in human pancreatic cancer. Koshiba T; Hosotani R; Wada M; Fujimoto K; Lee JU; Doi R; Arii S; Imamura M Surg Today; 1997; 27(4):302-4. PubMed ID: 9086544 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases. Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103 [TBL] [Abstract][Full Text] [Related]
6. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays. Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624 [TBL] [Abstract][Full Text] [Related]
8. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N Digestion; 1999; 60(3):246-54. PubMed ID: 10343138 [TBL] [Abstract][Full Text] [Related]
9. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [TBL] [Abstract][Full Text] [Related]
11. Local activity of matrix metalloproteinases in a case of botryoid sarcoma. Rechberger T; Postawski K; Skorupski P; Kotarski J; Jakowicki JA Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):169-72. PubMed ID: 8841807 [TBL] [Abstract][Full Text] [Related]
12. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005 [TBL] [Abstract][Full Text] [Related]
13. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer]. Sliwowska I; Kopczyński Z Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer. Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357 [TBL] [Abstract][Full Text] [Related]
16. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone. Bord S; Horner A; Hembry RM; Reynolds JJ; Compston JE J Anat; 1997 Jul; 191 ( Pt 1)(Pt 1):39-48. PubMed ID: 9279657 [TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma. Laird SM; Dalton CF; Okon MA; Bunning RA; Marshall R; Li TC J Reprod Fertil; 1999 Mar; 115(2):225-32. PubMed ID: 10434927 [TBL] [Abstract][Full Text] [Related]
18. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Davies B; Waxman J; Wasan H; Abel P; Williams G; Krausz T; Neal D; Thomas D; Hanby A; Balkwill F Cancer Res; 1993 Nov; 53(22):5365-9. PubMed ID: 8221672 [TBL] [Abstract][Full Text] [Related]
19. 72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection. Mellanen L; Salo T; Ingman T; Konttinen YT; Lähdevirta J; Sorsa T Acta Odontol Scand; 1998 Jun; 56(3):135-42. PubMed ID: 9688221 [TBL] [Abstract][Full Text] [Related]
20. A study of metalloproteinases in fifty joint fluid specimens. Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]